Financial Architects, Inc Gilead Sciences, Inc. Transaction History

Financial Architects, Inc

$657 Million
Q2 2023

A detailed history of Financial Architects, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Architects, Inc holds 2,794 shares of GILD stock, worth $319,717. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,794

Previous 2,756 1.38%

Holding current value

$319,717

Previous $228,000 5.7%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$76.01 - $86.7 $2,888 - $3,294	38 Added 1.38%	2,794 $215,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $17,085 - $19,465	221 Added 8.72%	2,756 $228,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $157,981 - $226,806	2,535 New	2,535 $217,000
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $184,822 - $231,602	-3,191 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $3,244 - $3,682	-50 Reduced 1.54%	3,191 $232,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $3,384 - $3,651	50 Added 1.57%	3,241 $226,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $33,004 - $36,062	-520 Reduced 14.01%	3,191 $220,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $4,200 - $4,792	-70 Reduced 1.85%	3,711 $240,000
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $53,902 - $67,773	-868 Reduced 18.67%	3,781 $239,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $11,791 - $13,692	163 Added 3.63%	4,649 $358,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $8,257 - $9,082	-134 Reduced 2.9%	4,486 $292,000
Q3 2019 Nov 06, 2019	BUY	$62.51 - $69.0 $8,376 - $9,246	134 Added 2.99%	4,620 $293,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $41,700 - $46,762	-674 Reduced 13.06%	4,486 $303,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $322,654 - $361,458	5,160 New	5,160 $336,000
Q1 2019 May 03, 2019	SELL	$62.53 - $70.05 $318,027 - $356,274	-5,086 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $88,933 - $116,051	-1,469 Reduced 22.41%	5,086 $319,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $129,800 - $143,713	-1,821 Reduced 21.74%	6,555 $506,000
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $50,152 - $58,500	-773 Reduced 8.45%	8,376 $593,000
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $124,119 - $151,315	-1,704 Reduced 15.7%	9,149 $690,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $59,481 - $69,822	-836 Reduced 7.15%	10,853 $777,000
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $842,893 - $999,058	11,689	11,689 $947,000

Others Institutions Holding GILD

# of Institutions

2,100

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $143B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Account

Financial Architects, Inc Gilead Sciences, Inc. Transaction History